DiaMedica Therapeutics (DMA) Reaches New 52-Week Low at $0.40

Share on StockTwits

DiaMedica Therapeutics Inc (CVE:DMA) shares reached a new 52-week low on Monday . The stock traded as low as C$0.40 and last traded at C$0.40, with a volume of 206600 shares. The stock had previously closed at C$0.42.

DiaMedica Therapeutics (CVE:DMA) last posted its earnings results on Wednesday, August 29th. The company reported C($0.03) EPS for the quarter, missing analysts’ consensus estimates of C($0.01) by C($0.02).

WARNING: “DiaMedica Therapeutics (DMA) Reaches New 52-Week Low at $0.40” was originally posted by Macon Daily and is the property of of Macon Daily. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://macondaily.com/2018/11/12/diamedica-therapeutics-dma-reaches-new-52-week-low-at-0-40.html.

DiaMedica Therapeutics Company Profile (CVE:DMA)

DiaMedica Therapeutics Inc, a clinical-stage biopharmaceutical company, engages in the development of treatments for neurological and kidney diseases. The company's lead product is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase II clinical trials for the treatment of acute ischemic stroke and kidney injury indications.

Featured Article: Return on Equity (ROE)

Receive News & Ratings for DiaMedica Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaMedica Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply